High Quality New HIV Medicine Bictegravir CAS 1611493-60-7, Pharmaceutical Raw Material Bictegravir 1611493-60-7, CAS NUMBER 1611493-60-7 Suppliers in China

Home > Products > GS > Bictegravir (GS-9883;GS9883;GS 9883) CAS Number 1611493-60-7

Bictegravir (GS-9883;GS9883;GS 9883) CAS Number 1611493-60-7

Bictegravir (GS-9883;GS9883;GS 9883) CAS Number 1611493-60-7

    Terms of Trade: CIF
    Min. Order: 1 Kilogram
    Delivery Time: 15 Days
    Packaging: As required
    Productivity: 10KG/M
    Transportation: Air
    Place of Origin: CHINA
    Certificate: Technical Support

Basic Info

Model No.: 1611493-60-7

Product Description

Bictegravir CAS number is 1611493-60-7, developed code is GS-9883, is a new class of integrase inhibitors. Unlike the previously developed integrase inhibitors, Bictegravir only needs to be used once a day without the synergist cobicistat. In the third phase of clinical trials, the TAF/FTC/BIC protocol was studied. Previous studies have shown that Bictegravir CAS number 1611493-60-7 is well tolerated in healthy people, inhibits renal tubular transporter, reduces creatinine levels, and causes a decrease in glomerular filtration rate, but does not impair renal function. In addition, Bictegravir has a higher resistance barrier than other integrase inhibitors and has less interaction with other drugs.
A two-stage clinical placebo double-blind controlled trial was presented at the 2017 CROI conference in Boston to compare the efficacy of Bictegravir and dolutegravir as first-line treatments. The results of the study indicate that the Bictegravir regimen is similar in efficacy to the dolutegravir regimen and has good safety and tolerability. Bictegravir is recommended as the first choice for first-line treatment in treatment guidelines. in Europe and the United States. Bictegravir is another heavy medicine that will be put on the market in the field of HIV medicine since TAF.

Thera. Category:Integrase Inhibitor

Cas No.:1611493-60-7

Synonyms:Bictegravir;GS-9883; Bictegravir (GS-9883)




Assay: ≥99%

Packing:Export worthy packing

Material Safety Data Sheet:Available on request

Taizhou Volsen Chemical Co., Ltd.


Taizhou Volsen Chemical Co., Ltd. is professional in R&D, producing and marketing Pharmaceutical raw materials, pharmaceutical intermediates in China. VOLSEN consists of about 100 experienced employees including 3 PhD and 10 Master, and 35000 sqm facilities including research laboratories, kilo lab, pilot plant and full manufacturing plant,

VOLSEN R&D specialists, quality manager and sales with abundance experience make sure products are reliable and service is professional. The producing person inspect every step of the whole process and check up the quality strictly, in order to insure every batch of raw material achieve the standard of EP,CP, JP,BP etc.Matching to the diversified requirements of companies VOLSEN is steadily marching to reach the peaks.

Volsen owns a professional custom synthesis department, with more than 15 senior scientific research chemical personnels who have a graduate degree or above. We also have an independent scientific management system. Our company integrates years of production experiences and talent reserves that forms a strong R&D production capacity, furthermore we could undertake various chemicals customizations from kg to ton relying on the existing production base and equipment.

Manufacturing Unit is equipped with a facility of progressive reeducation of emissions, effluents and discharge of waste material that are known to have a negative impact on the environment. Besides, Laboratory as well as plant is equipped with latest Machinery, Equipments, Technical personnel & Means of communications.

Due to supply of reliable quality, efficient follow up, scheduled delivery and prompt response to any matter, company wins good comments from customers.

We aimed at delivering real business value to our clients. For any interest, pls call on us or email us to get our best services.

Company Info

  • Company Name: Taizhou Volsen Chemical Co., Ltd.
  • Representative: Mr Chen
  • Product/Service: Favipiravir Intermediates , Arbidol Intermediates , Relugolix Intermediates , Vilanterol Intermediates , Remdesivir Intermediates , Umeclidinium Bromide
  • Capital (Million US $): 60000000RMB
  • Year Established: 2002
  • Total Annual Sales Volume (Million US $): Above US$100 Million
  • Export Percentage: 91% - 100%
  • Total Annual Purchase Volume (Million US $): Below US$1 Million
  • No. of Production Lines: 5
  • No. of R&D Staff: 91 -100 People
  • No. of QC Staff: 11 -20 People
  • OEM Services Provided: yes
  • Factory Size (Sq.meters): 30,000-50,000 square meters
  • Factory Location: Dongying Economic Development Zone , Dongying, Shandong,China
  • Contact Person: Ms. Amy Cheng
  • Tel: 86-576-88869393
Email to this supplier
  • *Subject:
  • To:

  • *Messages:
    Your message must be between 20-8000 characters